BACKGROUND: Food restriction has been demonstrated to increase the alertness in different species and to increase the levels of the wake-promoting neurotransmitter orexin. We hypothesized that diurnal intermittent fasting (DIF) increases orexin-A levels during fasting. Therefore, we conducted this study to assess the effects of DIF, during the month of Ramadan, on orexin, while controlling for lifestyle changes that may accompany Ramadan such as sleep duration, bedtime and wake time, energy expenditure, light exposure, and food.
T he relationship between diurnal intermittent fasting (DIF) (represented mainly by fasting during Ramadan) and sleepiness is an interesting topic with contradicting results reported in previous studies. [1] In general, food restriction has been demonstrated to increase alertness in different species. [2] However, this topic is not well studied with respect to the DIF. Several studies have assessed daytime sleepiness during DIF during Ramadan both subjectively [3] [4] [5] [6] [7] [8] [9] [10] and objectively. [6, 8, 9] These studies reported contradictory results, which may be due to differences in the methods used to assess sleepiness, different populations and cultures, and lack of control for potential confounders that may accompany DIF such as light exposure, meal composition, and wake time and bedtime, which could potentially affect daytime alertness. [1] Therefore, it would be a good idea to measure the effects of DIF on levels of natural and endogenous markers of sleepiness and wakefulness, such as neurotransmitters. Sleep and wakefulness are controlled by a complex system that involves several sleep-promoting (inhibitory) and wake-promoting (excitatory) neurotransmitters. [11] A recently discovered hypothalamic neuropeptide that can be measured in blood plasma is orexin-A. Orexin-A (hypocretin-1) is a wake-promoting (excitatory) neurotransmitter secreted by the hypothalamus. There are two types of orexin, orexin-A and orexin-B (hypocretin-1 and hypocretin-2). Both are excitatory neuropeptides; however, orexin-A is more stable and more lipophilic than is orexin-B and can be measured in the cerebrospinal fluid (CSF) and plasma. [12] Orexin-A is usually affected by nutritional status and food intake. [13] Fasting has been shown to upregulate orexin gene expression in animal models. [2] Moreover, it has been shown that direct injection of orexin into the laterodorsal tegmental nucleus in animal models increased wake time. [14] However, as experimental fasting in animal models entails fasting that is usually more prolonged than the DIF practiced during Ramadan, findings extrapolated from animal studies cannot be extrapolated to Ramadan fasting.
Usually, orexin-A levels are measured in the CSF; however, plasma levels of orexin-A can be measured with good accuracy. [15] A strong correlation between CSF and plasma concentrations of orexin-A has been reported in healthy human subjects, as well as in mice. [16] It is postulated that the highly lipophilic orexin-A (but not orexin-B) rapidly enters the brain from the blood through a nonsaturable mechanism. [13] Plasma levels of orexin-A have been used to assess the response of sleepiness to positive airway pressure therapy in patients with obstructive sleep apnea (OSA). [15] Moreover, it has been shown that plasma levels of orexin-A have a significant linear correlation with daytime sleepiness in patients with OSA. [17] It has been hypothesized that the increased plasma levels of orexin-A in patients with OSA with daytime sleepiness indicate a physical response to increase wakefulness and counteract the effects of sleepiness. [17] Therefore, orexin-A appears to be a good marker to assess the sleepiness during DIF.
To the best of our knowledge, no study has assessed orexin-A levels in humans during DIF so far. Therefore, we conducted the present study to assess the effects of DIF on orexin-A levels in healthy human subjects. As orexin-A levels can be affected by light exposure, [18] sleep pattern, [18] and exercise, [19] we controlled for lifestyle changes that may accompany Ramadan such as sleep duration, bedtime and wake time, energy expenditure, light exposure, and food intake.
Methods

Subjects
Eight healthy, nonsmoker male volunteers between the ages of 20 and 30 years were included in the present study. Volunteers were recruited through advertising on bulletin boards in the local hospital and university. The project was approved by the Institutional Review Board of the College of Medicine, King Saud University, and informed consent was obtained. Inclusion criteria included not being on any medications or special diet, no history of smoking, alcohol drinking, no night shift work, and not being on vacation during the study period. Exclusion criteria included patients with documented medical, psychiatric, or sleep disorders. In addition, all participants were assessed by one of the authors to make sure that they had no medical problems or sleep disorders. Moreover, before enrollment, participants' sleep patterns were assessed via actigraphy (Philips/Respironics, Inc., Murrysville, PA, USA) (1 week of continuous monitoring), [20] and their circadian patterns were assessed via a validated Arabic version of the reduced Horne and Ostberg's Morningness-Eveningness questionnaire. [21, 22] All participants had the morning chronotypes and a regular wake/sleep pattern. A regular sleep pattern was defined as <1 h of daily variability in the bedtime and wake time. [23] The participants' work hours were from 07:30 to 16:30 before Ramadan and from 10:00 to 15:00 during Ramadan.
Study protocol
The present study is a repeated measures study. For details about study design, we refer the reader to previous studies assessing neurohormonal changes during Ramadan. [8, 24] The present study was conducted over the period starting the last week of Rajab (month 7, Hijri), the first and last weeks of Shaban (month 8, Hijri), and the 2 nd week of Ramadan (month 9, Hijri) in the Hijri year 1437 (corresponding to May 1-June 21, 2016). The Islamic Hijri calendar follows the lunar system. Each Hijri year contains 354 days, or 11 days fewer than the Gregorian year. As a result, the month of Ramadan occurs 11 days earlier every Gregorian year. [25] While at home during the study periods, sleep was monitored continuously using actigraphy.
Study periods Fasting outside Ramadan
Participants performed DIF similar to the Islamic intermittent fasting during Ramadan (i.e., abstinence from food and drinks between dawn and sunset) during the 1 st week of the Shaban (month 8, Hijri) and were admitted on the last day of the week. This intermittent fasting was introduced to simulate Islamic intermittent fasting outside of Ramadan (FOR) to control for the lifestyle changes and eating habits that accompany Ramadan and may affect sleep and sleepiness such as delays in the start time of work. [1] 
Baseline (nonfasting; baseline)
This admission occurred during the last week of Shaban (month 8, Hijri). During the 2 weeks that preceded this admission, the participants had a normal dietary routine.
Ramadan
This visit occurred during the last day of the 2 nd week of Ramadan (month 9, Hijri). Figure 1 shows the study protocol. An adaptation visit was done during the last week of Rajab (month 7, Hijri) to adapt to the sleeping environment and equipment used and to undergo an overnight sleep study (not included in the analysis) to minimize the "first night effect" [26] and to rule out sleep disorders. Body weight was measured at the beginning of the study and at the end of each of the study periods. Volunteers were asked to wear actigraphy equipment while at home to objectively assess their sleep schedule (Philips/Respironics, Inc.). [20] The actigraphy equipment was worn on the nondominant wrist. [20] For orexin-A measurements, the participants were admitted to the sleep laboratory three times (baseline [BL], FOR, and Ramadan). During each admission, participants spent 24 h at the laboratory and underwent overnight polysomnography (PSG). Participants were admitted to the laboratory at approximately 18:00. During the laboratory stay, the participants received meals with a fixed caloric content (35 Kcal/kg/24 h), and fixed proportions of carbohydrates, fats, and proteins. In addition, light exposure was controlled during the three study periods (baseline [BL], FOR, and Ramadan) to minimize its effect on sleepiness, circadian rhythm, and orexin-A levels. From 18:00 until bedtime, the light intensity was maintained at 50 lux. During sleep, all lights were turned off and the light intensity was <1 lux. During Suhur time, light intensity was maintained at <30 lux. [27] The light intensity was measured using SpectralStar Light Meter LX-1 (Japan).
Diurnal intermittent fasting protocol
We used the same intermittent fasting protocol described in previous studies. [8, 23, 24] During the fasting periods (FOR and Ramadan), the participants were asked to fast from dawn to sunset.
Time of meals in the laboratory
Meal timing was monitored during stays in the sleep laboratory. During BL, the participants had three meals: dinner at 20:00, breakfast at 07:15, and lunch at 12:00. During FOR and Ramadan, the participants had the following meals: breakfast (at sunset, between 18:30 and 18:45), dinner at 21:00, and Suhur (predawn meal) before dawn (between 02:55 and 03:10) to account for the changes in dawn and sunset times.
Timing of blood specimen collection
On the day of admission to the laboratory, an intravenous cannula and a peripheral intravenous line were fixed in the antecubital vein for blood withdrawal. Blood samples were collected at 22:00, 02:00, 04:00, 06:00, and 11:00. The samples were immediately centrifuged at 4°C and stored at −70°C.
Polysomnography
A standard level I attended PSG recording was performed during sleep while in the laboratory during the three study periods −BL, FOR, and Ramadan. The details have been described in previous publications.
[8] Alice 6 diagnostic equipment was used for data acquisition (Philips/Respironics, Inc.). The arousal index, which is a measure of sleep fragmentation, was defined as the number of arousals per hour of sleep. The number of "stage shifts" was defined as the total number of changes in sleep stage from lights out to lights on. Scoring was performed according to established scoring criteria. [28] Sleep and wake pattern and energy expenditure in the laboratory Daytime naps were not allowed while in the laboratory. During BL, bedtime was at 23:00 and rise time was at 07:00. During FOR and Ramadan, bedtime was 23:00. During Ramadan, the participants had a Suhur meal at approximately 03:00, and the participants went back to sleep at 03:45 until 07:45. During FOR, the participants had a Suhur meal at 03:10 (to account for the shift in the dawn prayer time), and the participants went back to sleep at 03:55, and slept until 07:45. As exercise may affect the level of orexin-A, energy expenditure was monitored while the participants were in the laboratory using a SenseWear Pro Armband ™ (Body Media, Pittsburgh, PA, USA). The technical characteristics of the armband have been previously described. [29, 30] In brief, the armband is a small portable sensor worn on the triceps of the right arm and provides information regarding the total energy expenditure and total sleep time. [31] The accuracy of the armband has been validated against double-labeled water and metabolic carts. [31] [32] [33] 
Determination of orexin-A levels
Plasma orexin-A levels were determined using a validated enzyme immunoassay system designed to measure orexin-A in plasma (Phoenix Pharmaceuticals, Burlingame, CA, USA). [34] The assay sensitivity for orexin-A was 0.22 ng/ml, and the specificity for detecting orexin-A was 100%. The intra-and inter-assay coefficients of variation were <5% and <14%, respectively. The measurement procedure was carried out according to the manufacturer's instructions.
Statistical analysis
Data are expressed in the text as the mean ± standard deviation. Energy expenditure was expressed as metabolic equivalents (METs). The average METs were calculated to obtain an overall hourly average for each day.
Comparisons of the BL, FOR, and Ramadan fasting groups were performed using a repeated measures analysis of variance (ANOVA). When the normality test failed, Friedman's repeated measures ANOVA on ranks test was used. Post hoc analyses were performed to determine the significant differences between individual groups. The results were considered statistically significant when they had P < 0.05. The data were analyzed using Statistical Package for Social Sciences software (versions 22; IBM Corporation, Armonk, NY, USA).
Results
Study group characteristics
The mean age of the participants was 25.4 ± 3.5 years and the mean body mass index was 24.4 ± 3.8 kg/m 2 . No changes occurred in body weight during the three study periods (71.2 ± 7.9 kg, 70.5 ± 6.6 kg, and 69.6 ± 10.8 kg for BL, FOR, and Ramadan, respectively, P = 0.3). In addition, no significant changes were detected in serum glucose measurements, while in the laboratory, measured at 15:30, in the three study periods (5.9 ± 0.6, 5.8 ± 0.5, and 5.5 ± 0.7 mmol/L during BL, FOR, and Ramadan, respectively).
Sleep/wake schedule while sleeping at home
While sleeping at home, there were no significant differences in bedtime and wake time between BL and FOR [ Table 1 ]. However, a significant delay in bedtime and wake-up time was observed during Ramadan, which supports previous studies' observations that lifestyle changes do occur during Ramadan. [1] No significant differences were detected between the nocturnal sleep duration and total sleep duration (nocturnal sleep and naps) during the three study periods.
Sleep parameters and energy expenditure during admission to the laboratory
No differences were detected in measured sleep parameters during the three study periods while admitted to the sleep laboratory [ Table 2 ]. No significant changes were found in energy expenditure during the three monitoring periods.
Orexin-A concentrations during the study periods
The pattern of orexin concentrations during BL, FOR, and Ramadan is shown in Figure 2 . Noticeably, during the fasting periods, orexin-A levels were lower at night and higher during daytime compared to during BL. This observation was more obvious during FOR. The difference between BL and both FOR and Ramadan was statistically significant at 06:00 (1.6 ± 0.7, 2.5 ± 0.8, and 2.4 ± 0.8, respectively) and at 11:00 (1.6 ± 0.3, 2.7 ± 0.5, and 2.4 ± 0.5, respectively). Moreover, the difference between BL and FOR was statistically significant at 22:00 (2.4 ± 0.9 vs. 1.6 ± 0.6, respectively) and at 02:00 (2.0 ± 0.3 vs. 1.6 ± 0.8, respectively). Although there was a clear trend of higher orexin-A levels at 04:00 during Ramadan and FOR compared to BL, the difference was not statistically significant [ Figure 2 ].
Discussion
Food restriction has been shown to increase wakefulness and to upregulate orexin gene expression in animal models. [2] However, to the best of our knowledge, the present study is the first to assess orexin-A levels during DIF. The results clearly demonstrate that orexin-A levels were lower at night and higher in the daytime during DIF. Our findings support previous data indicating that DIF does not cause sleepiness. [1, 25] A few previous studies that objectively assessed sleepiness indicated that DIF does not increase daytime sleepiness when controlling for the accompanying lifestyle changes that accompany Ramadan.
[1] The effects of intermittent fasting on drowsiness during and outside of Ramadan were objectively assessed. In a well-designed study that measured total blink duration (measured using infrared reflectance oculography) and mean reaction time under controlled conditions with fixed light/dark exposure, caloric intake, sleep/wake schedule, and sleep duration, intermittent fasting had no impact on drowsiness or vigilance. [35] Another study objectively assessed daytime sleepiness using the multiple latency test during Ramadan after controlling for potential confounders in 8 healthy volunteers and revealed no difference in sleep latency between the nonfasting BL, intermittent FOR, and during Ramadan. [8] The importance of the orexin system in vigilance control was realized recently, with the discovery that patients with narcolepsy, a chronic sleep disorder characterized by irresistible bouts of sleep, cataplexy, and dissociated manifestations of rapid eye movement sleep have orexin deficiency. [36] In patients with narcolepsy, the orexin-A level is usually measured in the CSF; however, we were not granted ethical approval to measure orexin-A levels in the CSF in healthy volunteers, because the blood plasma level of orexin-A is a good marker of orexin-A secretion from hypothalamic orexin + neurons and reflects the activity of these neurons. [15, 16] It has been proposed that mammals, when faced with a negative energy balance due to reduced food intake, respond with increased wakefulness and alertness in order to enhance their ability to find food. [36] A study has shown that, in orexin neuron-ablated mice, there is no fasting-induced arousal, which indicates that orexin neurons are necessary for the adaptive behavioral arousal during fasting. [37] It is thought that innervation of orexin neurons from regions that control metabolism and feeding such as the hypothalamic arcuate nucleus, nucleus tractus solitarius, and ventromedial hypothalamic nucleus is the likely mechanism enabling orexin neurons to react to the peripheral energy balance and stimulate arousal. [36] In addition, orexin neurons interact closely with the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system and are directly activated by corticotropin-releasing hormone and stress. [38] Stimulation of the sympathetic and HPA tone in response to fasting may further induce arousal through the orexin system. [39] In the current study, the trend of lower orexin-A levels at night and higher levels in the daytime was more obvious [40] During FOR, both factors were under control. Previous studies have shown that, in the free-living environment, there is a delay in the biological clock during Ramadan among Saudi people. [30] This may explain why the differences between daytime and nighttime orexin-A levels were more obvious during FOR than during Ramadan. Therefore, when assessing orexin levels, it is important to control for sleep/wake patterns and circadian rhythms. A major limitation of previous studies that assessed the effects of fasting during Ramadan on neurohormonal changes is the inability to control for lifestyle changes while at home. [1] Even in controlled studies such as the current study, sleep/wake pattern and hence, light exposure changed during Ramadan while at home, which may affect the measured variables, such as orexin-A levels. [1] The strength of this study is the fact that it is the first to assess the interaction between the recently discovered excitatory neurotransmitter orexin-A and DIF. In addition, the study was conducted under close monitoring and controlled for potential confounders that may affect orexin-A levels. However, the current study has some limitations that need to be addressed. As the participants were objectively monitored under controlled conditions in a short time period, only a relatively small number of volunteers were recruited. Nevertheless, the recruited number is typical in such experimental studies that use objective continuous assessment methods under controlled conditions that must be conducted within a limited time (the month of Ramadan). [23, 30, [41] [42] [43] [44] Second, this study was conducted among young healthy subjects; hence, the results cannot be generalized to the general population. Third, women were not included, as they have to break their fast while menstruating, and the total study period covered more than one menstrual cycle.
Conclusions
The current assessment of plasma orexin-A levels in young healthy subjects during and before Ramadan revealed that, under controlled conditions of light exposure, meals, and sleep-wake schedules, DIF increases orexin-A levels in the plasma during fasting hours. This finding supports previous studies in humans and animals, which showed that fasting increases alertness. Future larger studies are needed to confirm the current findings.
